Cite
Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication.
MLA
Artman, Chad, et al. “Avian Antibodies (IgY) Targeting Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Inhibit Receptor Binding and Viral Replication.” PLoS ONE, vol. 16, no. 5, May 2021, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pone.0252399.
APA
Artman, C., Brumfield, K. D., Khanna, S., & Goepp, J. (2021). Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication. PLoS ONE, 16(5), 1–14. https://doi.org/10.1371/journal.pone.0252399
Chicago
Artman, Chad, Kyle D. Brumfield, Sahil Khanna, and Julius Goepp. 2021. “Avian Antibodies (IgY) Targeting Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Inhibit Receptor Binding and Viral Replication.” PLoS ONE 16 (5): 1–14. doi:10.1371/journal.pone.0252399.